newsfilter
← Latest News
Business Wire·

AVROBIO Announces Completion of Patient Dosing in First Gene Therapy Clinical Trial for Cystinosis

First five patients in Phase 1/2 trial show systemic gene therapy effect across multiple tissues evaluated, including eyes, skin, gastrointestinal mucosa and neurocognitive system AVROBIO planning to initiate